ERBB2 and breast cancer: In a panel of breast cancer cell lines, those with PIK3CA mutation [12], HER2 amplification [24] or undetectable levels of PTEN expression [8], [25] all displayed Akt activation as assessed by elevated levels of Akt phosphorylation on threonine 308 and serine 473 (Figure 1A).